共 171 条
[1]
Grundy SM(2002)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 3143-421
[2]
Cleeman JI(2004)Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation. 110 227-239
[3]
Merz CN(2006)AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation. 113 2363-2372
[4]
Brewer HB(1985)Sick individuals and sick populations Int J Epidemiol. 14 32-38
[5]
Clark LT(2009)Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000 Am J Epidemiol. 170 229-236
[6]
Hunninghake DB(2000)Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations Lancet. 355 675-687
[7]
Smith SC(1999)Acute-phase proteins and other systemic responses to inflammation N Engl J Med. 340 448-454
[8]
Allen J(1990)Elevation of C-reactive protein in “active” coronary artery disease Am J Cardiol. 65 168-172
[9]
Blair SN(2003)High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study Circulation. 108 1560-1566
[10]
Bonow RO(1994)The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med. 331 417-424